Uniswen Pharmaceuticals Private Limited
About Uniswen Pharmaceuticals Private Limited
Data last updated:
Uniswen Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85100PN2016PTC164976. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Shailesh Shashikant Phaldessai and Rajendra Chandrashekhar Dixit.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Sno 82 7A7B8 Bldg No D4/5 Guru Ganesh Nagar Kothrud, Pune, Maharashtra, India – 411029.
As per the financials filed for FY 2020, the company reported a revenue of ₹22.76 Lakh, a growth of 34% compared to the previous year. For the same year it recorded a net loss of ₹21.78 Lakh (net margin -95.7%) and EBITDA of -₹21.78 Lakh (EBITDA margin -95.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Uniswen Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressSno 82 7A7B8 Bldg No D4/5 Guru Ganesh Nagar Kothrud, Pune, Maharashtra, India – 411029
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Uniswen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Uniswen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Uniswen Pharmaceuticals Private Limited, buy the company report.
Financials of Uniswen Pharmaceuticals Private Limited
FY 2020 filings availableUniswen Pharmaceuticals Private Limited reported revenue of ₹22.76 Lakh (up 34% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 34% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹22.76 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹21.78 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹21.78 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -95.7% | |||
| Net Profit Margin | -95.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Uniswen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Uniswen Pharmaceuticals Private Limited
Uniswen Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yashwant Shivram Bhujbal Also directs: Specura Pharmaceuticals Private Limited | Additional Director | 14 Jun 2017 | 9 Years 4 Months | Current |
| Shailesh Shashikant Phaldessai Also directs: Garf Entertainment LLP, Garphapona Foundation | Director | 14 Jun 2016 | 10 Years 4 Months | Current |
| Rajendra Chandrashekhar Dixit Also directs: Specura Pharmaceuticals Private Limited | Director | 14 Jun 2016 | 10 Years 4 Months | Current |
| Pandit Vilasrao Ghorpade | Director | 14 Jun 2016 | 10 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Uniswen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uniswen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Uniswen Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Uniswen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Uniswen Pharmaceuticals Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Yashwant Shivram Bhujbal was appointed as Additional Director on 14 Jun 2017.
Frequently asked questions
Uniswen Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2016 (10+ years old) and is registered under CIN U85100PN2016PTC164976.
Uniswen Pharmaceuticals has 4 current directors:
- Yashwant Shivram Bhujbal - Additional Director
- Shailesh Shashikant Phaldessai - Director
- Rajendra Chandrashekhar Dixit - Director
- Pandit Vilasrao Ghorpade - Director
The latest financial statements of Uniswen Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
No. Uniswen Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Uniswen Pharmaceuticals is U85100PN2016PTC164976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uniswen Pharmaceuticals was incorporated on 14 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
Yashwant Shivram Bhujbal was appointed as Additional Director on 14 Jun 2017. Pandit Vilasrao Ghorpade was appointed as Director on 14 Jun 2016. Rajendra Chandrashekhar Dixit was appointed as Director on 14 Jun 2016. Uniswen Pharmaceuticals has 4 board changes on record in total.
The registered office of Uniswen Pharmaceuticals is at Sno 82 7A7B8 Bldg No D45 Guru Ganesh Nagar Kothrud, Pune, Maharashtra, India – 411029.
Uniswen Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Uniswen Pharmaceuticals is compliant as of 30 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
